Patterns of failure after induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma: The Queen Mary Hospital experience

International Journal of Radiation Oncology Biology Physics

Volumn 49, Issue 5, 2001, Pages 1219-1228

  Chua, Daniel T T ^a   Sham, Jonathan S T ^a   Choy, Damon ^a   Kwong, Dora L W ^a   Au, Gordon K H ^a   Kwong, Philip W K ^a   Yau, Chun Chung ^a   Cheng, Ashley C K ^a   Wan, Koon Yat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Induction chemotherapy; Nasopharyngeal carcinoma; Patterns of failure; Radiotherapy

Indexed keywords

CARCINOGENS; ONCOLOGY; PATIENT MONITORING; RADIOTHERAPY;

CARCINOMA; NASOPHARYNGEAL;

CHEMOTHERAPY;

CISPLATIN; EPIRUBICIN;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; EXPERIENCE; FEMALE; FOLLOW UP; HONG KONG; HOSPITAL; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; STATISTICAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME; UNDIFFERENTIATED CARCINOMA;

ADOLESCENT; ADULT; AGED; ALOPECIA; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 0035312648     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)01522-4     Document Type: Conference Paper

References (25)

1. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma
2. Salvage surgery for recurrent primary nasopharyngeal carcinoma
3. Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma
4. Efficacy of radical neck dissection for the control of cervical metastasis after radiotherapy for nasopharyngeal carcinoma
5. Nonparametric estimation form incomplete observations
6. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985; Survival after local recurrence
7. Locally recurrent nasopharyngeal carcinoma; Treatment results for patients with tomography assessment
8. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma
9. Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma
10. The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx; An analysis of 1301 patients
11. Nasopharyngeal carcinoma; The Dana-Farber Cancer Institute experience with 24 patients treated with induction chemotherapy and radiotherapy
12. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy
13. Does induction chemotherapy have a role in the management of nasopharyngeal carcinoma? Results of treatment in the era of computerized tomography
14. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Results of a matched cohort study
15. Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma
16. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy
17. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma
18. VUMCA I Trial. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma; A positive effect on progression-free survival
19. Final results of the VUMCA I randomized trial comparing neoadjuvant chemotherapy (CT) (BEC) plus radiotherapy (RT) to RT alone in undifferentiated nasopharyngeal carcinoma (UNCT)
20. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer; Phase III randomized intergroup study 0099
21. A review of neoadjuvant chemotherapy for head and neck cancer; Partially shrunken tumors may be both leaner and meaner
22. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma; Toxicities and preliminary results
23. A phase III randomized trial comparing concurrent chemotherapy-radiotherapy with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma